Literature DB >> 1712731

Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts.

M A Horton1, M L Taylor, T R Arnett, M H Helfrich.   

Abstract

Studies with a range of monoclonal and polyclonal antisera to components of the human, rat, and chick vitronectin receptor, alpha V beta 3, and the VLA beta 1 chain show that chick and rat osteoclasts express similar integrin receptors to those described in man. Biochemical analysis with monoclonal antibody 23C6 confirmed the presence on chick osteoclasts of a vitronectin receptor heterodimer of similar size (110/95 kDa reduced) to that immunoprecipitated from human osteoclastoma giant cells. The synthetic peptide GRGDSP, corresponding to the cell adhesion sequence in fibronectin, but not GRGESP peptide, induced significant (P less than 0.005) osteoclast retraction in chick and rat osteoclasts at IC50s (+/- SEM) of 210.0 +/- 14.4 and 191.4 +/- 13.7 microM, respectively; monoclonal anti-vitronectin receptor alpha V beta 3 complex antibody, 23C6, produced similar changes in chick osteoclasts (IC50 = 1.45 +/- 0.22 microM). Antibody 23C6 inhibited the number of pits resorbed in dentine by chick osteoclasts over a concentration range of 4.4 to 88 micrograms/ml; a significant 76% reduction (P = 0.03) was observed at a final concentration of 88 micrograms/ml (6 microM). The effect of peptides upon dentine resorption was less dramatic. No consistent inhibition was seen using chick osteoclasts. Inhibitory effects on resorption by rat osteoclasts were, however, observed; significant reduction in resorption occurred with both GRGDSP (78%; P less than 0.01) and GRGESP (67%; P = 0.02) peptides at 400 microM peptide concentration. These data demonstrate that osteoclast function can be disrupted by low concentrations of the anti-vitronectin receptor antibody, 23C6. The inhibitory effects of the peptides used in this study produced effects on dentine resorption which were generally weaker and variable, although osteoclast cell adhesion was consistently inhibited in an Arg-Gly-Asp (RGD)-dependent manner. We conclude that the vitronectin receptor may play an important role in effecting resorption of mineralized tissues by osteoclasts.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712731     DOI: 10.1016/0014-4827(91)90386-9

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  43 in total

Review 1.  Regulation of osteoclast formation and function.

Authors:  L T Duong; G A Rodan
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

Review 2.  Calcium signaling in osteoclasts.

Authors:  Sung-Yong Hwang; James W Putney
Journal:  Biochim Biophys Acta       Date:  2010-11-11

3.  Dynamin forms a Src kinase-sensitive complex with Cbl and regulates podosomes and osteoclast activity.

Authors:  Angela Bruzzaniti; Lynn Neff; Archana Sanjay; William C Horne; Pietro De Camilli; Roland Baron
Journal:  Mol Biol Cell       Date:  2005-05-04       Impact factor: 4.138

Review 4.  Mechanisms for inhibition of P2 receptors signaling in neural cells.

Authors:  Fernando A González; Gary A Weisman; Laurie Erb; Cheikh I Seye; Grace Y Sun; Betty Velázquez; Melvin Hernández-Pérez; Nataliya E Chorna
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

5.  NFATc1 directly induces the human beta3 integrin gene in osteoclast differentiation.

Authors:  T N Crotti; M Flannery; N C Walsh; J D Fleming; S R Goldring; K P McHugh
Journal:  J Musculoskelet Neuronal Interact       Date:  2005 Oct-Dec       Impact factor: 2.041

Review 6.  Involvement of alpha(v)beta3 integrins in osteoclast function.

Authors:  Ichiro Nakamura; Le T Duong; Sevgi B Rodan; Gideon A Rodan
Journal:  J Bone Miner Metab       Date:  2007-10-25       Impact factor: 2.626

7.  Pitfalls in pit measurement.

Authors:  A Boyde; S J Jones
Journal:  Calcif Tissue Int       Date:  1991-08       Impact factor: 4.333

Review 8.  The role of alphav integrins during angiogenesis.

Authors:  B P Eliceiri; D A Cheresh
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

9.  Development of a new method for obtaining osteoclasts from endosteal surfaces.

Authors:  L G May; C V Gay
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-05       Impact factor: 2.416

Review 10.  Osteoclast motility: putting the brakes on bone resorption.

Authors:  Deborah V Novack; Roberta Faccio
Journal:  Ageing Res Rev       Date:  2009-09-27       Impact factor: 10.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.